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Abstract: Reverse vaccinology (RV) is a bioinformatics approach that can predict antigens with
protective potential from the protein coding genomes of bacterial pathogens for subunit vaccine design.
RV has become firmly established following the development of the BEXSERO® vaccine against
Neisseria meningitidis serogroup B. RV studies have begun to incorporate machine learning (ML)
techniques to distinguish bacterial protective antigens (BPAs) from non-BPAs. This research
contributes significantly to the RV field by using permutation analysis to demonstrate that a signal for
protective antigens can be curated from published data. Furthermore, the effects of the following on
an ML approach to RV were also assessed: nested cross-validation, balancing selection of non-BPAs
for subcellular localization, increasing the training data, and incorporating greater numbers of protein
annotation tools for feature generation. These enhancements yielded a support vector machine (SVM)
classifier that could discriminate BPAs (n = 200) from non-BPAs (n = 200) with an area under the
curve (AUC) of 0.787. In addition, hierarchical clustering of BPAs revealed that intracellular BPAs
clustered separately from extracellular BPAs. However, no immediate benefit was derived when
training SVM classifiers on data sets exclusively containing intra- or extracellular BPAs. In conclusion,
this work demonstrates that ML classifiers have great utility in RV approaches and will lead to new
subunit vaccines in the future.
Keywords: reverse vaccinology; machine learning; support vector machine; bacterial protective antigen;
bacterial pathogen
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1. Introduction
Reverse vaccinology (RV) is a form of vaccine research that uses bioinformatics approaches
to identify putative vaccine candidates in the protein coding genomes of bacteria (i.e., proteomes).
The most successful RV study to date was by Pizza and colleagues [1] and led to a subunit vaccine
against Neisseria meningitidis (N. meningitidis) serogroup B [2]. Initially, open reading frames in the
genome of N. meningitidis serogroup B were identified and bioinformatics programs (psortB [3],
ProDom [4], and Blocks databases [5]) used to predict the subcellular localization for every protein
in the proteome. Extracellular predicted proteins were then cloned and expressed as recombinant
proteins, purified and had their predicted surface expression confirmed through techniques such
as enzyme-linked imunosorbent assay (ELISA) and fluorescence activated cell-sorting (FACS).
Proteins with confirmed surface expression were then used to generate antibodies in the serum
of immunized mice and the bactericidal activity of this serum was assessed. Examples that met these
criteria were then screened for conservation across multiple MenB strains and their suitability for
manufacturing in bulk was assessed [6]. In the final subunit vaccine, BEXSERO®, three proteins were
selected for incorporation, (i.e., Factor H binding protein, Neisserial adhesion A, and Niesseria heparin
binding antigen) along with a detergent extracted outer membrane vesicle (DOMV). The BEXSERO®
vaccine is now licensed in over 35 countries and has already had an impact on the mortality and
morbidity associated with N meningitidis serogroup B [7].
The RV approach of Pizza et al. [1] may be classified as a “filtering” approach, i.e., the organism’s
proteome is passed through a series of filters until a subset of proteins are identified that represent
potential vaccine candidates. Several utilities have been developed to implement filtering approaches
to RV, for example Violin [8], Jenner Predict [9], and Ivax [10]. Drawbacks of filtering methods include
the necessity of assessing large numbers of candidates in the laboratory and potential candidates
with predicted subcellular localization other than extracellular (e.g., cytoplasmic) are discarded [11].
The latter is a significant limitation since proteins predicted to be cytoplasmic or of unknown
localizations have been shown to confer significant levels of protection in animal models [12–19].
Machine learning (ML) approaches to RV circumvent these problems since they do not discard such
proteins but are able to successfully model the entire proteome of a bacterial species and rank predicted
antigens for their likelihood of being a vaccine candidate [20,21].
The first ML study in the field of RV was published by Doytchinova and Flower [21], in which
a training dataset was generated of 100 known antigens through a literature curation that defined
a known antigen as a protein (or part of a protein) that, “has been shown to induce a protective response
in an appropriate animal model after immunization”. A negative training dataset was constructed by
randomly sampling 100 proteins or non-antigens from the same bacterial species that corresponded
to each known antigen in the positive training dataset. The proteins in this training dataset were
annotated with auto cross-covariance (ACC) transformations, which reflect hydrophobicity, molecular
size, and polarity. The annotated proteins were used to train a classifier based on discriminant
analysis by partial least squares (DA-PLS), which was able to achieve an accuracy of 82% when
distinguishing non-antigens from known antigens. In an extension to Doytchinova and Flower’s [21]
work, our initial RV study [20] focused exclusively on bacterial protective antigens (BPAs) defined as,
“a whole protein that led to significant protection (p < 0.05) in an animal model (i.e., bacterial load
reduction or survival assay) following immunization and subsequent challenge with the bacterial
pathogen”. Focusing on bacterial proteins the size of the training data (136 BPAs and 136 non-BPAs)
was increased and then annotated with biologically-relevant protein annotation tools (e.g., PSORTb [3],
LipoP [22], and Bepipred [23]) for the training of support vector machine (SVM) classifiers. This work
showed that higher accuracies were obtained when using SVMs (i.e., 92%) when separating BPAs and
non-BPAs in the training data and when recalling known antigens in the background of entire bacterial
proteomes [20].
Building on our previous work in the field of ML applied to RV, this current study implemented
a nested approach to cross-validation, removed an artificial bias associated with the selection of
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non-BPAs for the negative training data, increased the size of the training data by approximately
a third, and incorporated new protein annotation tools to model different aspects of immunogenicity
(e.g., T-cell epitope prediction and Adhesin prediction [24]). The resulting SVM classifier was used to
demonstrate that a significant signal for protection could be captured through the literature curation
of BPAs as assessed through comparisons to randomly-permutated data.
2. Results
2.1. Permutation Analysis Reveals a Strong Protective Signal for BPAs Curated from the Literature
To enhance the biological relevance of ML classifiers for RV, several modifications were made to
our previous approach [20]. These included adopting a nested (N) cross-validation approach, balancing
(B) the negative training data for subcellular localization, increasing the size of the positive training
dataset to 200 BPAs, and increasing the number of protein annotation tools by 15 to derive a total of
525 annotation features (AF) (full list Table S1). This resulted in a training data set with the designation
BPAD200+N+B+AF consisting of 200 BPAs and 200 non-BPAs annotated with 525 features. Non-BPAs
in the negative training data were selected by randomly sampling proteins from the same bacterial
proteome for the relevant BPA pair while ensuring the same subcellular localization.
Initially, the BPAD200+N+B+AF dataset was used to determine if a signal for protective
efficacy had been captured when curating BPAs from the literature record. SVM classifiers were
trained in a nested leave tenth out cross-validation (LTOCV) approach to discriminate BPAs from
non-BPAs in BPAD200+N+B+AF and in five additional data sets where the labels (i.e., BPA or
non-BPA) were randomly permutated (permutation testing) and, thus, contained no biological
information. Greedy backward feature elimination was used to select different numbers of features
for SVM classifiers. For each feature set, the difference in the AUC calculated from receiver operator
characteristic (ROC) curves between BPAD200+N+B+AF and the randomly permutated data was
calculated (Figure 1A). An SVM classifier with the 10 most informative features led to a significant
separation in AUC (average p-value 1.13 × 10−12, DeLong test [25]) between BPAD200+N+B+AF
and the randomly permutated data (Figure 1B). These results clearly demonstrated that the literature
curation of BPAs captured a strong protective signal and that 10 features was the optimal number for
discriminating BPAs from non-BPAs. Therefore, SVM classifiers containing 10 features were used to
evaluate the changes in classification accuracies of each of the modifications to our RV approach.
2.2. A Nested Approach Has a Significant Impact on the Ability of SVMs to Classify BPAs
Having demonstrated that the SVM classifier BPAD200+N+B+AF trained on datasets curated
from the literature had captured a biological signal reflective of protective antigens, the multiple
modifications made to our RV approach were assessed in a stepwise manner. The starting
point for this assessment was the BPAD136 classifier from our previous work [20], consisting
of 136 BPAs and 136 non-BPAs. The following modifications to BPAD136 were then assessed
in turn: nested cross-validation (BPAD136+N), balancing non-antigen selection for subcellular
localization (BPAD136+N+B), increasing the size of training data, (BPAD200+N+B) and, finally,
incorporating additional features (BPAD200+N+B+AF). Our previous work [20] had not implemented
a truly nested cross-validated approach and it was hypothesized that previous SVM classifiers may
have overfit the data. This was indeed the case, as reflected by a significant reduction in AUC
(p-value = 9.69 × 10−5, DeLong test [25]) when migrating from an overfit (BPAD136, AUC = 0.962) to
a nested (BPAD136+N, AUC = 0.861) approach (Figure 2). Therefore, the implementation of a nested
approach to cross-validation is recommended for RV studies and enables a better estimation of the
performance of SVM classifiers.
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Figure 1. (A) Plot of the difference in area under the curve (AUC) between the support vector machine
(SVM) classifier BPAD200+N+B+AF versus randomly permutated data with increasing feature numbers.
SVM classifiers were trained to discriminate bacterial protective antigens (BPAs) and on-BPAs in
BPAD200+N+B+AF and receiver operator characteristic (ROC) curves generated from a nested leave
tenth out cross-validation approach for different numbers of features selected by greedy backward
feature elimination. Five iterations were performed to assess the random breakage of ties during greedy
backward feature elimination and AUC was averaged across iterations for each feature set. This analysis
was then repeated for five datasets where the BPA and non-BPA labels were randomly permutated and
average AUC calculated across randomly permutated data sets for each feature set; (B) ROC curves for the
average of the five iterations of the 10 feature SVM classifier derived from BPAD200+N+B+AF (black solid
line) and from each of the five randomly-permutated datasets (dotted grey lines).
2.3. Correcting a Bias in the Selection of Negative Training Data Impacts SVM Classification of BPAs
The subcellular localizations predicted by PSORTb [3] were compared between the positive (BPAs)
and negative (non-BPAs) training data for BPAD136. This demonstrated that the negative training data
had a larger proportion of proteins predicted to be located in the cytoplasm (Figure 3A,B). This resulted
from the random selection of non-BPAs for the negative training data. Specifically, for each BPA,
a non-BPA was randomly selected from the proteome of the same bacterial species. Since the majority
of proteins in any given bacterial proteome are predicted to be cytoplasmic, random sampling led
to a disproportionate number of non-BPAs with this subcellular location in the negative training
data. To correct this bias, a new negative training dataset was generated, where each non-BPA was
selected to match not only the bacterial species of the corresponding BPA, but also its subcellular
localization (Figure 3C). Removing this bias in subcellular localization decreased the ability of the
SVM classifier to discriminate between BPAs and non-BPAs as reflected in a significant reduction
in AUC (p-value of 3.44 × 10−5, DeLong test [25]) when comparing BPAD136+N to BPAD136+N+B
(Figure 2). The performance of the SVM classifier is reduced because it can no longer utilize differences
in subcellular localization to discriminate BPAs from non-BPAs. This is reflected by the removal of
features related to bacterial subcellular localization (e.g., PSORTb and SignalP) from the top 10 features
utilized by the classifier.
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Figure 2. ROC curves w re generated fro cl ssifiers utilizing 10 features select d by greedy
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of SVM classifiers implemented to rando l rea ties resulting from the greedy backward feature
elimination procedure. The benchmark to assess these modifications was a non-nested, non-balanced
training data set of 136 BPAs and 136 non-BPAs annotated with 122 features from 19 protein
annotation tools (BPAD136) [20]. Subsequent modifications were added in a stepwise fashion and
included: a nested cross-validation approach (BPAD136+N), balanced selection of non-BPAs for
predicted subcellular localization (BPAD136+N+B), increased size of training data (BPAD200+N+B),
and additional features (525 total) derived from an increased number of protein annotation tools
(BPAD200+N+B+AF).
2.4. Increasing the Size of the Training Data Has a Positive Impact on the Ability of SVMs to Classify BPAs
A literature curation yielded 64 new BPAs that were significantly protective (p < 0.05) in an animal
model following immunization and subsequent challenge with the bacterial pathogen. These BPAs
were used to expand the positive training data set from 136 to 200 BPAs and paired with non-BPAs
balanced for subcellular localization to form the training data set designated BPAD200+N+B. Increasing
the size of the training data in this manner led to improvements in AUC (Figure 2, 0.697 to 0.735),
although this change was not statistically significant.
2.5. Increasing the Number of Protein Annotation Tools Enhances the Ability of SVMs to Classify BPAs
The effect of incorporating new annotation features derived from protein annotation tools (Table S1)
with biological relevance for immunogenicity (e.g., Spaan [26], MHCpan [27], GPS-MBA [28]) on the
ability of SVM classifiers to distinguish BPAs from non-BPAs was examined. Compared to our original
approach [20], an additional 15 protein annotation tools were assessed resulting in a training data set
(BPAD200+N+B+AF) annotated with a total of 525 features. The incorporation of these additional
features resulted in an SVM classifier with an increased AUC (0.787) when compared to BPAD200+N+B.
Although this increase did not attain significance, it should be stressed that when the incorporation of
additional BPAs and features were considered together (i.e., BPAD136+N+B to BPAD200+N+B+AF)
there is a significant increase in AUC (p = 2.11 × 10−2, DeLong test [25]). Finally, the top 10 features
selected by greedy backward feature elimination for the discrimination of BPAs and non-BPAs in the
BPAD200+N+B+AF dataset contained new features primarily related to T-cell epitopes (Table 1).
Int. J. Mol. Sci. 2017, 18, 312 6 of 15
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Figure 3. Pie charts showing subcellular localization as predicted by PSORTb [3] for the numbers
of BPAs and non-BPAs in the following subsets of the BPAD136 dataset. (A) positive training data
(i.e., 136 BPAs); (B) negative training data (i.e., 136 non-BPAs); and (C) negative training data balanced
for subcellular localization (i.e., 136 non-BPAs).
Table 1. The top 10 annotation features selected by greedy backward feature elimination for discrimination
of BPAs from non-BPAs by the SVM classifier trained on the BPAD200+N+B+AF data set.
Rank Feature Name ofBioinformatics Tool Protein Annotation Tool Type
Correlated with
BPA or Non-BPA
1 LipoP_Signal_Avr_Length LipoP Lipoprotein BPA
2 YinOYang-T-Count YinOYang Glycosylation BPA
3 NetPhosK-S-Count NetPhosK Phosphorylation BPA
4 LipoP_SPI_Avr_Length LipoP Lipoprotein BPA
5 NetMhcPan-B-AvgRank NetMhc T-Cell Epitope predictor(MHC Class II) BPA
6 TargetP-SecretFlag TargetP Subcellular Compartmentalisation—In Eukaryotic Cells BPA
7 YinOYang-Average-Difference1_Length YinOYang Glycosylation Non-BPA
8 MBAAgl7_CorCount GPS-MBA T-Cell Epitope predictor BPA
9 PickPocket-Average_score PickPocket MHC Peptide Binding Non-BPA
10 PropFurin-Count_Score ProP Cleavage Sites—In Eukaryotic Cells BPA
Features in bold represent those derived from protein annotation tools that were added in this study compared to
our previous approach [20]. For a full list of bioinformatics tools utilized in this study and the annotation features
derived from them please see Table S1.
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2.6. Intracellular and Extracellular BPAs Utilize Different Features for Classification
An unsupervised approach was used to further explore the biological signals in the features
derived from protein annotation tools used to annotate the 200 BPAs curated from the literature record.
Hierarchical clustering of the 142 BPAs not predicted to have an unknown subcellular localization by
psortB [3] using all 525 annotation features revealed two main groups that primarily corresponded to
predicted subcellular localization, i.e., intra- or extracellular (Figure 4). This suggests that intracellular
and extracellular BPAs may have fundamentally different biological properties. Therefore, it was
hypothesized that greater accuracies would be achieved when SVM classifiers were trained separately
on intra- and extracellular BPAs. To test this hypothesis, two training datasets were constructed from
BPAD200: intracellular BPAD51 (iBPAD51) consisting of 51 BPAs and 51 non-BPAs with subcellular
localization predicted as intracellular, and extracellular BPAD91 (eBPAD91) with 91 BPAs and
90 non-BPAs with subcellular localization predicted as extracellular. A matching non-BPA balanced for
subcellular localization could not be found that met the inclusion criteria for ACF35754.1 (a BPA from
Salmonella enterica subsp. enterica serovar Paratyphi A), detailed in the Methods (Section 4.1) and, thus,
the negative training data was reduced by one.
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Figure 4. Hierarchical clustering of 142 BPAs from BPAD200+N+B AF using all 525 annotation features,
distances between BPAs were calculated using Euclidean metrics and then clustered using the Ward
algorithm. White labels at the branch tips refer to BPAs with subcellular localization predicted by
PSORTb [3] as intracellular (i.e., cytoplasm or cytoplasmic membrane) and black labels as extracellular
BPAs (i.e., extracellular, periplasmic, outer membrane, cell wall).
Contrary to expected findings, SVM classifiers trained on iBPAD51 and eBPAD91 had lower AUC
values compared to those trained on BPAD200 (Figure 5A). However, SVM classifiers had been trained
on datasets of different sizes and this might explain the superior performance of BPAD200, which was
the largest dataset. Therefore, SVM classifiers were trained on randomly selected subsets of BPAD200
of decreasing size (Figure 5B). This facilitated a better comparison of intra- (trained on iBPAD51) or
extracellular (trained on eBPAD91) SVM classifiers, versus those trained using BPAs and non-BPAs
from all subcellular localizations (BPAD200). However, the accuracies derived from iBPAD51 and
eBPAD91 were similar to data sets of similar size consisting of BPAs from all subcellular localizations
(Figure 5B). This suggests there is no immediate benefit to training separate SVM classifiers to recognize
intra- or extracellular BPAs.
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Figure 5. (A) ROC curves obtained from SVM classifiers trained to distinguish BPAs from non-BPAs
in the following data sets: iBPAD51 (dotted line), eBPAD91 (solid grey line) and BPAD200+N+B+AF
(black line). Curves were drawn by averaging results from five iterations of SVM classifiers consisting
of 10 features selected by greedy backward feature elimination assessed in a LTOCV approach;
(B) Plot showing the average percentage accuracy (five iterations) of SVM classifiers of 10 features
trained on different sized subsets of BPAD200+N+B+AF for comparison to SVM classifiers derived
from iBPAD51 and eBPAD91.
Finally, to fully explore differences between SVM classifiers trained on intra- (iBPAD51) and
extracellular (eBPAD91) BPAs, the top 10 features selected by greedy backward feature elimination
for each classifier were interrogated (Table 2). The SVM classifier trained on eBPAD91 (extracellular
classifier) utilized features derived from protein annotation tools that were not utilized by the classifier
trained on iBPAD51 (intracellular classifier) and were related to the following diverse array of biological
phenomena: an adhesin predictor SPAAN [26] (which describes if the protein adheres to the surface
of cells), surface accessibility, and secondary structure predictor NetSurfP [29] (which predicts the
relative likelihood of sections of each protein being exposed on the surface of a protein structure),
lipoprotein prediction LipoP [22] (which predicts if a protein will interact with lipids), as well as
a cleavage site predictor NetChop [30] (which predicts if a protein will be chopped by the human
proteasome) (Table 2A). Features derived from protein annotation tools that were unique to the
SVM classifier trained on iBPAD51 were largely related to immunogenicity and included: a B-cell
epitope predictor [23] (predicts possible binding sites for B-cells), a T-cell epitope predictor [28]
(predicts possible binding sites for T-cells) and a calpain cleavage predictor [31] (predicts a specific type
of protein cleavage dependent on the presence of Ca2+) (Table 2B). In summary, SVM classifiers appear
to utilize features from different protein annotation tools to discriminate intra- and extracellular BPAs
from their respective non-BPAs. There may be benefit to deriving separate classifiers for both types of
BPA in the future as the literature record expands allowing larger training data sets to be interrogated.
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Table 2. The top 10 annotation features selected by greedy backward feature elimination utilized by
SVM classifiers trained on (A) eBPAD 91 and (B) iBPAD51.
(A)
Rank Feature Protein Annotation Tool Type
Rank in
Intracellular
Classifier
1 Pad-value Adhesin 42
2 DictOGlyc_Ser_Average_Threshold_Length Glycosylation 189
3 LipoP_SPI_AvrScore Lipoprotein NF
4 Netsurfp_RSA_Exposed_AverageDiff Surface accesibility and secondary structure NF
5 PoloPhosphorylation_CorAvg Phosphorylation NF
6 Net_Chop_CorCount Predicts cleavage sites NF
7 DictOGlyc-No_Score_Sites_Length Glycosylation NF
8 GPS_SUMO_Sumoylation_Average_Score Small ubiquitin like modifiers (SUMOs) binding site prediction 9
9 ProtParam-PercIsoleucine General Annotation 144
10 ProtParam-PercGlutamicAcid General Annotation NF
(B)
Rank Feature Protein Annotation Tool Type
Rank in
Extracellular
Classifier
1 Bepipred-Count_Length B-Cell Epitope 149
2 CCD_av_diff Calpain Cleavage NF
3 YinOYang-T-Average-Difference1_Length Glycosylation NF
4 ProtParam-GRAVY General Annotation 35
5 NetOGlyc-T-Max-I Glycosylation 196
6 YinOYang-T-Average_Length Glycosylation NF
7 ProtParam-PercAlanine General Annotation 97
8 NetPhosK-Y-MaxScore Phosphorylation NF
9 GPS_SUMO_Sumoylation_Average_Score Small Ubiquitin like modifiers (SUMOs) binding site predictor 8
10 MBAAgl7_CorAvg T-Cell Epitope predictor NF
Protein annotation tools listed in bold represent those not present in the other classifier type. NF: not found in
the top 200 features of the other classifier type that were submitted to the greedy backward feature elimination
algorithm following non-specific F-score filtering.
3. Discussion
An SVM classifier capable of discriminating BPAs from non-BPAs was evaluated in a fully-nested
approach while examining the impact of the addition of new BPAs curated from the literature record
and additional annotation features derived from new protein annotation tools. The major finding was
that a signal of protective efficacy can be curated from published data in the form of BPAs defined
in this study. This was evident from the significant drop in accuracy of SVM classifiers trained on
randomly permutated data (Figure 1). To reiterate, a BPA was defined as a whole protein that led to
significant protection (p < 0.05) in an animal model (i.e., bacterial load reduction or survival assay)
following immunization and subsequent challenge with the bacterial pathogen.
The most biologically relevant classifier generated in this study was built upon the dataset
designated BPAD200+N+B+AF (Figure 2). The top 10 features used by this classifier may be
examined to determine which features are reflective of protective efficacy (Table 1). The main
signal related to protective efficacy in these top 10 features was the prediction of T-cell epitopes
(bioinformatics tools NetMHC [27] and MBAAgl7 [28]) with a greater number of epitopes associated
with protection as expected. In addition, annotation related to general biological processes, such as
threonine glycosylation, phosphorylation, and lipoproteins, are positively linked with protection.
These processes have previously been implicated in controlling both the humoral and cellular immune
responses [32–36]. For example, lipoproteins have been shown to increase the influence of major
histocompatibility complex-II (MHC-II) activation on T-helper cells (Th cells) [33]. This is achieved by
lipid rich microdomains co-localizing and increasing the MHC-II molecules concentration on the cell
surface, resulting in more efficient Th cell activation while requiring less antigen [33]. In summary,
although epitope prediction clearly has value in an RV approach, other tools predicting general protein
annotation features should also be considered and continue to be incorporated in future enhancements.
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Clustering BPAD200+N+B+AF revealed that BPAs grouped based on extracellular and intracellular
predicted subcellular localization (Figure 4). Unexpectedly, separate Intracellular (trained on iBPAD51),
Extracellular (trained on eBPAD91), and Combined (BPAD200+N+B+AF) classifiers achieved similar
accuracies (Figure 5). However, it was theorized that intracellular and extracellular classifiers would
be selecting different features in order to capture biological differences whilst making predictions of
BPA or non-BPA. A logical hypothesis would be that extracellular classifiers utilize features related
to B-cell epitopes since this antigen type is surface exposed and that intracellular classifiers require
features related to T-cell epitopes since this antigen type is internalized. However, this was not exactly
the case, whereby the intracellular classifier utilizes features from both B-cell and T-cell epitope
predictors but the extracellular classifier does not utilize features from any epitope prediction tools
(Table 2). This could be due to the difficulty in predicting conformational epitopes from amino acid
sequences [37], it is estimated that 90% of B-cell epitope binding is conformational [38]. To model
this information CBTOPE [39] (a conformational B-cell epitope predictor) was included in this study,
however annotation features derived from CBTOPE were not present in the top ten annotation features
used in classification for any of the classifiers trained in this study. It is possible that with more advanced
techniques these conformational epitopes will be more accurately predicted from amino acid sequences
and may become an important part of the classification for extracellular BPAs from non-BPAs. Instead
the extracellular classifier uses annotation features derived from more general protein annotation tools
(e.g., adhesin prediction, surface accessibility, and general cleavage site prediction). Although the
utility of separate intra- and extracellular classifiers has not been demonstrated in this study it is clear
that these classifier types are modelling different aspects of antigen biology and future studies will
explore this as more data becomes available.
There are a number of limitations that may be affecting the ability of SVM classifiers to discriminate
BPAs from non-BPAs. Firstly, it is possible that the random selection of non-BPAs for the negative
training data may result in the mistaken addition of protective antigens (i.e., BPAs) that simply have not
been tested and documented in the literature record. To negate this limitation, non-BPAs with homology
to BPAs were discarded. Furthermore, permutation analysis demonstrated that the non-BPAs represent
useful negative training data since there was clearly a discriminatory signal between BPAs and
non-BPAs (Figure 1B). Another limitation is that the features on which the classifiers are trained are all
generated from protein annotation tools. These tools are not 100% accurate and therefore some tools
will introduce noise into the annotation used to train SVM classifiers. Future studies should continue
to add new features from protein annotation tools as they are developed to asses if improvements to
classifier accuracy can be achieved. Regardless, the annotation features derived from protein annotation
tools currently available produce sufficient signal to significantly distinguish classifiers from randomly
permutated data (Figure 1B). Finally, most antigens previously tested and confirmed in the literature
are predicted to be of unknown subcellular localization (29%) or are extracellular (45.5%, eBPAD of
BPAD200). This led to a small training dataset (iBPAD51) when building the intracellular classifier
described in this study (51 BPAs and 51 non-BPAs). Incorporating more proteins in the training
datasets may enable better description of differences in protection derived through intracellular or
extracellular proteins.
It is envisaged that the application of ML approaches to RV will build upon the success of
filtering approaches that lead to the BEXSERO® vaccine. The SVM classifiers constructed in this
study discriminate BPAs from non-BPAs and through comparisons to randomly permutated data
clearly demonstrate that a signal for protective efficacy can be curated from the literature record.
Future studies should concentrate on the expansion of the training data through the addition of further
BPAs curated from the literature record and the incorporation of new protein annotation tools since
these enhancements significantly increased the accuracy of SVM classifiers. This will increase the
accuracy with which BPAs are predicted and reduce the number of laboratory assays that need to be
performed in order to identify novel antigens with the required protective efficacy.
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4. Methods
4.1. Training Data
A literature curation identified 64 new BPAs which were combined with 136 previously
characterized BPAs [20] for a positive training dataset totaling 200 BPAs. A BPA is a bacterial protein
that has led to significant protection (p < 0.05) in an animal model (i.e., bacterial load reduction
or survival assay) following immunization and subsequent challenge with the bacterial pathogen.
BPAs were only selected for inclusion if a consensus for this definition was met by two or more
curators. Negative training data (non-BPA) was generated by randomly selecting a protein from the
same bacterial species for each BPA. BLASTP was used to discard any non-BPAs that matched to
known BPAs (i.e., >98% similarity) or non-BPAs already selected (E-value < 10 ×10−3) [20]. Similarity
is a measure of the extent to which sequences are related and E-values are a representation of the
same sequence occurring by chance, both are described fully in the NCBI BLAST help manual [40].
In addition, unless otherwise stated, non-BPAs were selected from the same predicted subcellular
localization as their BPA partner. One BPA (ACF35754.1) did not have a predicted extracellular protein
(same subcellular localization) that matched the BLASTP inclusion criteria and a protein with unknown
subcellular localization was sampled instead for inclusion in the negative training dataset. In summary,
a dataset consisting of 200 BPAs and 200 non-BPAs was constructed and referred to throughout this
study as BPAD200.
4.2. Permutation Analysis
Permutation analysis was used to determine the optimal feature number for SVM classifiers.
Labels (BPA and non-BPA) were randomly permutated five times, generating five datasets.
Permutation analysis should destroy the antigenic signal and is fully described by Good [41].
The AUCs achieved when training SVM classifiers using greedy backward feature elimination on these
datasets were averaged and compared to five iterations of greedy backward feature elimination of
BPAD200+N+B+AF. This process was repeated with SVM classifiers trained with different numbers
of features.
4.3. Data Annotation
A second literature curation identified new protein annotation tools to generate novel annotation
features for training SVM classifiers. This study increased the number of protein annotation tools
from 19 in our previous work [20] to 34, and the output from these tools was parsed to generate
525 annotation features. Annotation tools included in the previous study [20] had their outputs parsed
in a standardized manner for all annotation tools. Protein annotation tools for eukaryotic proteins
were initially included to maximize the data on which SVM classifiers were trained. Classifiers trained
on datasets including additional annotation features not previously utilised in ML approaches to RV
have the AF tag, and a full list of protein annotation tools and annotations features can be found in
Table S1.
4.4. Machine Learning Classification
Annotation features were scaled individually between −1 and 1 before training SVM classifiers on
BPAs and non-BPAs [42]. A table of scaled annotation features as submitted to the classification pipeline
can be found as Table S2. All implementations of the SVM in this manuscript used a non-specific
filtering step based on F-score [43,44] to reduce the number of annotation features to 200. These features
then underwent greedy backward feature elimination [45] to remove the least informative feature
each round until the desired number of features remained. Backward selection was used to enable
the interaction of all features to be considered. When features have equal information content the
algorithm randomly selects which feature to remove, SVM classifiers were trained in five separate
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iterations to assess the impact of randomly breaking such ties. A full description of SVM classifiers has
been published by Noble [46].
To enable comparison to previous RV studies [20] SVMs with a radial bias function (RBF) kernel
were used to construct classifiers, as implemented in the libsvm package [42] in Python following
the libsvm user manual guidelines [47]. Unless otherwise indicated, classifiers were evaluated using
a nested LTOCV model [48] to obtain SVM predicted probabilities for each protein within the training
data of BPAs and non-BPAs. The first step in a fully nested approach was to split the data into 10 parts
and isolate one of these tenths as the test dataset. Feature selection and parameter optimization were
applied to the remaining training dataset only (i.e., the remaining 9/10 of the data). An SVM classifier
was then built on only the training dataset and used to predict the class (BPA or non-BPA) of the test
data in the one-tenth left out. This process was repeated a further nine times leaving the remaining
tenths of the data out one at a time.
4.5. Statistics
ROC curves were used to evaluate the performance of SVM classifiers in this study, and
generated by plotting the true positive rate (TPR, i.e., sensitivity) over the false positive rate
(FPR, i.e., 1−specificity) [49]. Area under the curve (AUC) values were calculated from ROC curves
and differences between AUC values was assessed with the DeLong [25] statistical test and p < 0.05
considered significant.
4.6. Hierarchical Clustering
The subcellular localization of BPAs from BPAD200+N+B+AF was predicted using the protein
annotation tool PSORTb [3]. A BPA was labeled as extracellular if it was predicted to be localized
close to the surface of the cell (i.e., cell wall, extracellular, outer membrane, or periplasmic).
BPAs with a predicted subcellular localization of periplasmic were included in the extracellular
group as these proteins clustered predominantly with the extracellular opposed to intracellular
group. If a BPA was predicted to be localized to the cytoplasm or cytoplasmic membrane it was
defined as intracellular. Intracellular and extracellular BPAs from BPAD200 were clustered on all
annotation features using a Euclidean distance calculation and a Ward clustering metric using the
ClassDiscovery [50], and Dendextend [51] packages in R [47].
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Abbreviations
RV Reverse Vaccinology
ML Machine Learning
BPA Bacterial Protective Antigen
BPAD Bacterial Protective Antigen Dataset
SVM Support Vector Machine
LTOCV Leave Tenth Out Cross Validation
iBPAD Intracellular Bacterial Protective Antigen Dataset
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eBPAD Extracellular Bacterial Protective Antigen Dataset
ELISA Enzyme-linked Imunosorbent Assay
FACS Fluorescence activated cell-sorting
DOMV Detergent Extracted Outer Membrane Vesicle
ACC Auto Cross Covariance
DA-PLS Discriminant Analysis by Partial Least Squares
RBF Radial Bias Function
TPR True Positive Rate
FPR False Positive Rate
ROC Receiver Operating Characteristic
AUC Area Under the Curve
N Nested
B Balanced
AF Additional Features
HDL High Density Lipoprotein
Th cells T-helper cells
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